Multicenter clinical trial of cefetamet pivoxil vs cefixime in treatment of acute bacterial infections / 中国新药与临床杂志
Chinese Journal of New Drugs and Clinical Remedies
;
(12): 87-90, 2001.
Artículo
en Chino
| WPRIM
| ID: wpr-411490
ABSTRACT
AIM:
To evaluate the safety and efficacy of cefetamet pivoxil vs cefixime in the treatment of acute bacterial infections.METHODS:
A multicenter randomized controlled clinical trial was conducted. Ninety-eight patients (M 43, F 55; age 40 a± s 13 a) with acute bacterial infections of cefetamet group were given cefetamet pivoxil 250-500 mg, po, bid, for 7-14 d, and ninty-five patients (M 44, F 51; age 42 a±14 a) of cefixime group were given cefixime 200 mg, po, bid, for 7-14 d.RESULTS:
The overall clinical efficacy rates were 95 % and 94 %, the bacterial clearance rates were 96 % and 94 %, the bacterial sensitive rates were 98 % and 96 %, the adverse reaction rates were 7 % and 6 %, respectively. There was no statistical significance between two groups (P>0.05).CONCLUSION:
Cefetamet pivoxil and cefixime are effective and safe in the treatment of acute bacterial infections.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Chino
Revista:
Chinese Journal of New Drugs and Clinical Remedies
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS